The key is being able to distinguish between the ‘tigers’ in prostate cancer from the ‘pussy cats.
We need to quickly recognise and treat the dangerous, aggressive prostate cancers but equally ensure that we don’t over treat men whose disease is slow-growing and not clinically significant.
The PSA test has been the traditional benchmark for assessing risk of prostate cancer. PSA stands for prostate specific antigen, a protein made by the prostate which naturally leaks into the bloodstream when the prostate is damaged.
A simple blood test can be taken to measure levels of PSA and a high reading indicates prostate cancer may be present. However a high reading can also be caused by non-cancerous conditions, such as an enlarged prostate, or BPH (Benign Prostatic Hyperplasia). Continue reading ‘Prostate Cancer – More Accurate, Individual Risk Assessment and Advanced Surgery’ »